it's not about what it's worth... only what people think it's worth it is better to remain silent and be thought a fool... Jesse Livermore: ”Throughout all my years of investing I’ve found that the big money was never made in the buying or the selling. The big money was made in the waiting.” Peter Lynch once said, “Far more money has been lost by investors preparing for corrections, or trying to anticipate corrections, than has been lost in corrections themselves.” to be cont'd
Decided to invest a quarter of my 401k myself and have been pretty successful along with other holdings outside of it - update that to really successful. Used a quarter of my 401k to quadruple the total 401k. One more big hit and I can retire at 55. TEAR, PLUG helped me the most and now I am into CRDC/Cardica, Anyone with any information with regards to this company would be most appreciated. It is 53% institutionally owned and just completed its first surgery in the US with little hoopla. They have a history of success in Europe. Other sizeable personal holdings are CRDC, RMTI, SO, KEY and MEET.
I now own over 10,000 shares of DXTR bought at an average of about $4.40.
I have a diverse background—as a financial journalist, resident physician, mixed martial artist, painter, entrepreneur, chemistry instructor and web developer—that enabled me to pioneer the “Integrated Investing Research” approach.
I provide consulting to clients, both the retail and professional investors. I accurately forecasted many clinical trials, such as the Flint Trials for Intercept, the Ascend Trials for InterMune and the Affinity Trials MannKind, just to name a few. Through Vincata Enterprises, LLC, I helped many clients to unlock substantial values for their investments.
As an expert in biopharmaceutical analysis, I am also more than capable of analyzing any other industries. Though not shown on Seeking Alpha, I have picked an aggregate basket of outperforming stocks.
Investing in biotech is highly risky, but it can be quite rewarding when investors have an edge in data analysis. Physicians who are rigidly scientific tend to lack the analytical prowess of financial experts. Conversely, financiers usually do not possess a physician’s medical expertise. Likewise, scientists are skillful in data analysis; yet they might not be familiar with a physician’s prescribing patterns, which is a requisite to successful biotech investing.
You can visit my website at https://www.retailinvestor360.com for business inquiry.
I try to carefully trade weekly & monthly stock options with expertise in mining companies & traditional manufacturers. Speak & write fluent Portuguese and speak good Spanish. Resided twice in Brazil and once on Guam Island. Employed at the same large foreign-owned Distribution Center the past 15 years & completely 100% Pro-NAFTA. Smart individual investing is the preferred solution to improving one's economic future, as opposed to vast & vague government handouts. Seeking Alpha is the #1 best financial blog because of honest opinions & superb organization.
Founder of BoatysOptions, an options trading newsletter emphasizing high probability trades and proper position sizing so you can day and swing trade options confidently and profitably.
Performance is what its all about! No market gibberish, just reinforcing options trading principles and strategies through BoatysOptions trade alerts. Follow me on twitter @boatysoptions
it's not about what it's worth... only what people think it's worth
it is better to remain silent and be thought a fool...
Jesse Livermore: ”Throughout all my years of investing I’ve found that the big money was never made in the buying or the selling. The big money was made in the waiting.”
Peter Lynch once said, “Far more money has been lost by investors preparing for corrections, or trying to anticipate corrections, than has been lost in corrections themselves.”
to be cont'd